Senior Director of Development (TGRIF)

The Translational Genomics Research Institute is dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with neurological disorders, cancer, diabetes, and infectious diseases through cutting edge, translational, bench-to-bedside research. TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities worldwide, TGen makes a substantial contribution to its patients through efficiency and effectiveness of the translational process.

TGen has joined forces with City of Hope to accelerate the speed with which scientists and medical staff convert research discoveries into cures for patients. The alliance is based on a simple premise: City of Hope provides a state-of-the-art clinical setting in which to advance genomic breakthroughs made by TGen. It is a collaboration that plays to the strengths of each organization. City of Hope is a pioneer in the fields of bone marrow transplantation, hematologic malignancies, select solid tumors, and diabetes. TGen, meanwhile, is a leader in applying genomic analysis and bioinformatics to drug development. Together, they are transforming the diagnosis, treatment, and prevention of cancer and other life-threatening diseases.

Raising the philanthropic resources to fuel leading-edge research, compassionate clinical care, and the advancement of biomedical education and training is a vital component of the TGen/City of Hope model of success. The two philanthropic foundations collaborate on philanthropic goals, and the Chief Development Officer of TGen Foundation reports to the Chief Philanthropy Officer at City of Hope. The shared culture is one of collaboration, accountability, and activation. 


The Aspen Leadership Group is proud to partner with the Translational Genomics Research Institute Foundation (TGen) in the search for a Senior Director of Development.

Reporting to the Vice President of Individual Giving, the Senior Director of Development will ensure fundraising success by serving as a subject matter expert, a professional role model, a program architect, and an identified team and program leader. The Senior Director of Development will be responsible for securing individual, corporate, and foundation gifts with an emphasis on gifts of $100,000 and above through sustainable, mission-focused cultivation, solicitation, and stewardship of donors. The Senior Director of Development will employ and model key processes and programs that support an office-wide focus on collaboration, efficiencies, and metrics-based performance outcomes. The Senior Director of Development will be a part of TGen's evolution into a perpetually campaign-ready, donor-centered, leading industry program in support of the joint mission of TGen and City of Hope. Through the development and implementation of best practices, the Senior Director of Development will contribute to TGen’s overall focus on a best in class fundraising operation. The Senior Director of Development will serve as a senior member of the Office of Philanthropy team, playing an important role in the growth of a more sustainable and rigor based philanthropic program.


Click here for more information or to apply. A bachelor's degree is required for this position as is at least five years of consecutive experience in a nonprofit environment, with experience in a complex health care environment preferred, including at least two years of supervisory experience. All applications must be accompanied by a cover letter and résumé. Cover letters should be responsive to the mission of the Translational Genomics Research Institute Foundation –  to positively impact the lives of patients and their families, as well as the responsibilities and qualifications presented in the prospectus. 


Showing 1 reaction

Please check your e-mail for a link to activate your account.
  • Erin Roberts
    published this page in Job Board 2021-04-14 19:39:23 -0400